Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mucor infection: difficult diagnosis.

Margarida Badior1, Fernanda Trigo, Catarina Eloy

  • 1Hematology Department, Hospital de São João, Porto, Portugal. margaridabadior@gmail.com

Clinical Drug Investigation
|February 6, 2013
PubMed
Summary

Mucormycosis is a rare, aggressive fungal infection in immunocompromised patients. Early detection and treatment are crucial for survival, as highlighted in a case of acute promyelocytic leukemia initially misdiagnosed as Aspergillus infection.

Related Concept Videos

Fungal Group Zygomycota01:29

Fungal Group Zygomycota

Zygomycota, previously classified as a distinct fungal group, are primarily terrestrial, saprophytic molds that play a crucial role as decomposers. Recent phylogenetic studies have revealed that these fungi are now divided into two major clades — Mucoromycota, which includes many symbiotic species, and Zoopagomycota, which primarily consists of parasitic and pathogenic fungi. These groups exhibit distinct ecological roles and reproductive strategies while sharing key structural and...
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improved real-world outcomes of patients with acute promyelocytic leukaemia treated with first-line arsenic trioxide in specialized centres in Portugal through a 24/7 phone-based referral.

British journal of haematology·2026
Same author

How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathology.

Journal of pathology informatics·2026
Same author

The European society of pathology progress test: towards a European external quality control tool for pathology education.

Virchows Archiv : an international journal of pathology·2026
Same author

Artificial intelligence enhances cancer cell selection for HER2 gene amplification assessment in breast carcinoma.

Virchows Archiv : an international journal of pathology·2026
Same author

Real-World Outcomes of FLAG-Ida Regimen in 1079 Adult Patients With First Relapsed/Refractory AML: A PETHEMA Study.

American journal of hematology·2026
Same author

Systemic and Local Adiposity in the Bone Marrow Microenvironment Associated With Improved Prognosis in Hodgkin Lymphoma: Imaging and Molecular Analysis.

International journal of cancer·2026

Area of Science:

  • Mycology
  • Infectious Diseases
  • Hematology

Background:

  • Mucormycosis is a severe opportunistic infection affecting immunocompromised individuals.
  • Prompt diagnosis and treatment are vital for improving patient outcomes.
  • Acute promyelocytic leukemia (APL) patients are at increased risk for invasive fungal infections.

Observation:

  • A case report details an immunocompromised patient with acute promyelocytic leukemia.
  • The patient initially received antifungal therapy for a suspected pulmonary Aspergillus infection.
  • Histological examination of resected lung tissue revealed mucormycosis, not aspergillosis.

Findings:

  • Histological analysis confirmed mucormycosis, necessitating a change in diagnosis and treatment.
  • The initial misdiagnosis of pulmonary Aspergillus infection delayed appropriate antifungal therapy for mucormycosis.

Related Experiment Videos

Implications:

  • High index of suspicion for Mucor species is essential for early diagnosis in at-risk patients.
  • Timely and appropriate antifungal therapy significantly impacts the prognosis of mucormycosis.
  • This case underscores the importance of accurate histopathological diagnosis in managing invasive fungal infections in immunocompromised hosts.